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Summary 
Background: The polycystic ovary syndrome (PCOS) is a
frequent endocrine disorder that affects women of repro-
ductive age. As the syndrome is strongly associated with
obesity, it is of interest to examine the gene expression
diffe rences that accompany its development and the
associ a ted metabolic disturbances. Real-time RT PCR is a
standard method for studying changes in gene expression.
However, to obtain accurate and reliable results, validation
of reference genes is obligatory. The aim of this study was
to identify a suitable reference for the normalization of gene
expression in peripheral blood mononuclear cells (PBMCs)
from obese and normal-weight women with PCOS.
Methods: The expression stability of four potential refer-
ence genes: hypoxanthine guanine phosphoribosyl trans-
ferase 1 (HPRT), b-actin (BA), b2-microglobulin (B2M) and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
was assessed in PBMCs from healthy women, and from
normal-weight and obese women with PCOS. The variabil-
Kratak sadr`aj
Uvod: Sindrom policisti~nih jajnika (PCOS) ~est je endokrini
poreme}aj od koga obolevaju `ene u reproduktivnom perio-
du. Budu}i da se PCOS ~esto javlja u komorbiditetu sa
gojazno{}u, ispitivanja promena u ekspresiji gena koje mogu
da doprinesu razvoju PCOS-a i prate}ih metaboli~kih
poreme}aja su od velikog zna~aja. RT PCR u realnom vre-
menu predstavlja standardnu metodu za prou~avanje pro -
mena u genskoj ekspresiji. Me|utim, u cilju dobijanja ta~nih
i pouzdanih podataka, neophodno je sprovesti validaciju re -
ferentnih gena. Cilj ovog rada je da identifikuje odgovaraju}i
referentni gen koji bi se koristio za normalizaciju ekspresije
gena u perifernim mononuklearnim }elijama pacijentkinja
normalne telesne te`ine i gojaznih `ena obolelih od PCOS-a.
Metode: Stabilnost ekspresije ~etiri potencijalna referentna
gena: hipoksantin-guanin-fosforibozil-transferaze 1 (HPRT),
b-aktina (BA), b2-mikroglobulina (B2M) i gliceraldehid-3-fos-
fat-dehidrogenaze (GAPDH) ispitana je u perifernim mono -
nuklearnim }elijama zdravih `ena, kao i `ena normalne
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Introduction
Polycystic ovary syndrome (PCOS) is a frequent
endocrinopathy that affects 6–8% of women of repro-
ductive age (1). The major determinants of PCOS are
hyperandrogenism, chronic anovulation and poly -
cystic ovaries (2). Usually, PCOS is associated with
metabolic disturbances such as abdominal obesity,
hyperinsulinemia and dyslipidemia (3). Approximately
40–60% of women with PCOS are overweight or
obese, and obesity has profound effects on both the
pathophysiology and the clinical manifestation of this
disorder (4–6). The mechanisms underlying the
PCOS remain largely unclear. Therefore, it is of inte -
rest to examine the differences in gene expression
that may contribute to the different pathophysiologi-
cal aspects of PCOS and the associated metabolic
disturbances including obesity. 
Real-time RT PCR is a convenient method for
studying changes in gene expression, often used in
biomedical research (7, 8). However, its accuracy and
reliability critically depend on the selection of a nor-
malization strategy (9, 10). Normalizing target gene
expression to a stably expressed reference gene is the
most commonly used normalization approach. The
use of an inappropriate reference gene can lead to
under- or over-estimation of the target gene expres-
sion level and to misinterpretation of the results, that
might have significant implications (10–12). There -
fore, to obtain an accurate result of the comparison of
mRNA levels between different samples, tissues, or
pathophysiological conditions, it is crucial to choose a
suitable reference gene. 
Due to the complex nature of PCOS, it is of
great importance to clearly define experimental
groups and to include validation of reference genes in
the process of evaluating target gene expression. In
this study, we examined four candidate reference
genes: b2-microglobulin (B2M), b-actin (BA), hypo -
xanthine guanine phosphoribosyl transferase1 (HPRT)
and gly ceraldehyde-3-phosphate dehydrogenase
(GAPDH), in order to identify a suitable reference for
the normalization of gene expression in peripheral
blood mononuclear cells (PBMCs) from obese and
normal-weight women with PCOS.
Materials and Methods
Subjects
This study was performed on three groups of
subjects: (a) normal-weight women with PCOS
(BMI<25 kg/m2), (b) obese women with PCOS (BMI ≥
30 kg/m2), and (c) normal-weight controls. Eighteen
women participated in the study (6 per group). 
The PCOS diagnosis was established according
to the Rotterdam/ESHRE consensus criteria (13)
including 2 of the following 3 criteria: 1) oligomenor-
rhea or anovulation; 2) clinical and/or biochemical
signs of hyperandrogenism, and 3) polycystic ovaries.
Oligo menorrhea was defined as bleeding intervals
between 35 days and 6 months and amenorrhea was
defined as a bleeding interval greater than 6 months
(14). Level of serum progesterone of less than 10
nmol/L was used for defining anovulation. In women
with regular menstrual cycles, anovulation was estab-
lished when two consecutive serum progesterone lev-
els in the luteal phase were less than 10 nmol/L.
Modified Ferriman-Gallwey (F-G) score higher than 6
was used to diagnose hirsutism (15). Based on a pre-
vious report by Macut et al. (16), hyperandrogenemia
was defined by the level of serum total testosterone
higher than 2 nmol/L. Ovarian morphology was exam-
ined by transvaginal ultrasonography, and presence of
in creased ovarian volume and/or at least twelve follic-
ular cysts measuring 2–9 mm were used for confirm-
ing their polycystic structure (17). All the subjects with
regular menstrual cycles were evaluated during the
early follicular phase. All relevant drugs (oral contra-
ceptives, glucocorticoids, antiandrogens, ovulation
ity in the expression of potential reference genes was ana-
lyzed by the TaqMan real-time RT PCR method, using
GeNorm and NormFinder software packages. 
Results: Direct comparison of cycle threshold (Ct) values
showed inter-individual variations for all validated genes,
the Ct values of HPRT being less variable than those of BA,
GAPDH and B2M. Both software packages pointed to
HPRT as the most steadily expressed gene in the PBMCs of
women with PCOS and healthy controls. 
Conclusions: Cross-validation of the expression stability of
four potential reference genes identified HPRT as the most
stable reference, suitable for further investigations of gene
expression in PBMCs from women with PCOS.
Keywords: HPRT, PCOS, peripheral blood mononuclear
cells, real-time RT PCR, reference gene
telesne te`ine i gojaznih `ena obolelih od PCOS-a.
Varijabilnost ekspresije potencijalnih referentnih gena je ispi-
tana TaqMan metodom RT PCR-a u realnom vremenu,
kori{}enjem softverskih paketa GeNorm i NormFinder.
Rezultati: Direktnim pore|enjem Ct vrednosti zapa`ene su
interindividualne razlike kod svih ispitivanih gena, ali su Ct
vrednosti HPRT-a najmanje varirale u odnosu na vrednosti
BA, GAPDH i B2M. Oba softverska paketa su pokazala da
je HPRT gen sa najstabilnijom ekspresijom u perifernim
mono nuklearnim }elijama zdravih `ena i `ena obolelih od
PCOS-a.
Zaklju~ak: Unakrsna ispitivanja stabilnosti ~etiri potencijal-
na referentna gena pokazala su da je HPRT najstabilniji re -
ferentni gen i da je, kao takav, pogodan za dalja ispitivanja
promena u genskoj ekspresiji u perifernim mononuklear -
nim }elijama `ena sa PCOS-om. 
Klju~ne re~i: HPRT, PCOS, sindrom policisti~nih jajni-
ka, periferne mononuklearne }elije, RT PCR u realnom vre-
menu, referentni gen
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inducing agents, antidiabetic and antiobesity drugs,
or other hormonal therapy) were excluded or prohib-
ited for at least 3 months preceding the study.
Excluding criteria in this study were: hyperglycemia,
thyroid disease, pregnancy, and prolactin-, cortisol- or
androgen-secreting tumors. Study participants were
consecutively recruited during a one-year period from
the Outpatient Endocrinology Clinic, where they were
referred for evaluation of menstrual cycle distur-
bances, hirsutism, acne or fertility problems. 
All the subjects gave written informed consent
for participating in this study and the Ethical
Committee of the Faculty of Medicine, University of
Belgrade, approved the protocol.
Biochemical and hormonal measurements
After overnight fasting, blood samples were
drawn at 08:00 h and stored at –20 °C until use.
Serum total testosterone (nmol/L) and sex hormone-
binding globulin (SHBG, nmol/L) concentrations
were determined by radioimmunoassay using
TESTO-CT2 and SHBG-RIACT kits (CIS bio interna-
tional, Gif-Sur-Yvette Cedex, France). The intra- and
inter-assay coefficients of variation were: 4.5 and
5.1% for testosterone, and 3.9 and 4.7% for SHBG.
Standard formula [(testosterone/SHBG) × 100] was
used for calculation of the free androgen index (FAI). 
RNA isolation and cDNA synthesis 
PBMCs were prepared from fresh blood by cen-
trifugation through Ficoll-Paque PLUS (Amersham,
UK). Total mRNAs were isolated from PBMCs by an
RNeasy mini kit (Qiagen). Concentration and purity
were tested spectrophotometrically (OD 260/280
higher than 1.8 was considered acceptable). The
integrity of RNA was assessed by agarose gel elec-
trophoresis. After adding the RNase inhibitor (Applied
Biosystems), samples were frozen at –80 °C until use. 
cDNA was synthesized from 2 mg of RNA after
removal of DNA by DNAse I treatment (Fermentas).
Reverse transcription reaction was performed using a
High Capacity cDNA Reverse Transcription kit (Applied
Biosystems). cDNA was stored at –80 °C until use. 
Real-time PCR 
Real-time PCR was performed using the ABI
Prism 7000 Sequence Detection System (Applied
Bio systems). The reaction mixture contained 1 ×
TaqMan Universal Master Mix with AmpErase UNG,
1 × Assay Mix (Applied Biosystems) and cDNA
template (20 ng of RNA converted to cDNA).
Primers and probes for the glucocorticoid receptor
(GR, Hs00230813_m1), BA (Hs99999903_m1),
B2M (Hs99999907_m1), GAPDH (Hs99999905_m1)
and HPRT (Hs99999909_m1) were obtained from
Applied Biosystems.
The cycle conditions were: 95 °C for 10 min and
subsequently 40 cycles at 95 °C for 15 s and 60 °C
for 90 s. All the reactions were run in triplicates. For
the evaluation of PCR efficiencies of all the examined
genes and GR as a target gene, serial dilutions of one
randomly chosen cDNA were made and amplified,
and standard curves were constructed. 
Data analysis
Data are presented as mean values ± SD.
Between group comparisons of anthropometrical and
basal biochemical parameters were made by non-
parametric Kruskal-Wallis H test and subsequently by
Mann-Whitney U test (SPSS v13.0, SPSS INC.,
Chicago, IL, USA). A value of P<0.05 was consid-
ered statistically significant. 
Results
All the anthropometrical and hormonal param -
eters are presented in Table I. In comparison to nor-
Table I Main anthropometrical measures and basal hormonal concentrations in normal-weight and obese women with PCOS
and healthy controls.
Values are means ± S.D. BMI, body mass index; SHBG, sex hormone-binding globulin; FAI, free androgen index. aNonparametric
Kruskal-Wallis H test followed by Mann-Whitney U test if P<0.05; bP<0.01 vs obese PCOS; cP<0.05 vs obese PCOS; dP<0.01
vs Controls; eP<0.05 vs Controls.
Variable Controls Normal-weight PCOS Obese PCOS Pa
Age (years) 29.17±4.16 23.50±3.93 28.67±5.05 0.21
BMI (kg/m2) 22.67±2.88b 22.97±2.47b 32.82±2.80 0.003
Waist circumference
(cm) 78.00±8.74
b 80.83±13.53c 102.17±7.55 0.012
Waist-to-hip ratio 0.81±0.05 0.83±0.04 0.88±0.07 0.13
Testosterone (nmol/L) 1.58±0.59 3.18±0.52d 2.55±0.78e 0.01
SHBG (nmol/L) 56.50±13.86 32.84±9.89e 19.02±9.41d 0.005
FAI 3.06±1.57 10.01±1.91d 17.50±6.76d 0.004
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mal-weight PCOS women and healthy controls, the
obese women with PCOS had a significantly higher
BMI and waist circumference. As expected, total
testosterone and FAI were significantly higher, while
SHBG was significantly lower in both PCOS groups
than in controls.
In order to evaluate the expression stability of
selected potential reference genes in PBMCs from
obese and normal-weight women with PCOS, first we
calculated the PCR amplification efficiencies. For the
construction of a standard curve, serial dilutions of
one randomly chosen cDNA sample were amplified.
The slope of a standard curve (semi-log regression
line of Ct vs log of cDNA input) is used for estimating
the amplification efficiency of the PCR reaction
(Figure 1). Slope of –3.32 corresponds to 100% effi-
ciency. Amplification efficiencies (E) of the candidate
reference genes and GR, as a target gene, were cal-
culated using the formula: E = (10-1/slope – 1) ×
100, and are presented in Table II. Amplification effi-
ciency values ranged from 91% to 104% (slope –3.23
to –3.55), and r2 values of the standard curves were
over 0.993.
For relative quantification by the DDCt method,
the amplification efficiencies of the reference and tar-
get gene should be approximately equal. The easiest
way to check whether two genes have similar ampli -
fication efficiencies is to examine how the Ct value
(Cttarget gene – Ctreference gene) varies with sample dilu-
tion. The two genes have equal efficiencies if the
slope of semi-log plot (Ct vs log of cDNA input) is less
than 0.1. In this study, all the examined reference
genes performed well, as compared to the GR as a
target gene (data not shown).
Expression stability of potential reference genes
was analyzed by the direct comparison of Ct values
and by using GeNorm (18) and NormFinder (19)
software. First, the individual Ct values of the exam-
ined reference genes were compared. Expression pro-
files of B2M, BA, GAPDH and HPRT are presented in
Figure 2. Raw data displayed a wide expression range,
with Ct values between 21 and 31 (Figure 2). B2M
and BA were the most abundant genes, followed by
GAPDH, while the least abundant gene in the PBMCs
of all the examined subjects was HPRT. Each gene
showed marked inter-individual variations, with stan-
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Figure 1 Amplification efficiencies of candidate reference genes (B2M, BA, GAPDH and HPRT) and GR as a target gene.
Table II Gene symbol, molecular function and amplification efficiency of GR and four candidate reference genes.
Gene Symbol Gene Name Function Amplification efficiency E (%)
BA b-Actin Cytoskeletal structural protein 96
B2M b2-Microglobulin
b-Chain of major histocompatibility 
complex class I molecule 91
GAPDH Glyceraldehyde-3 phosphate dehydrogenase Glycolytic enzyme 104
HPRT Hypoxanthine guanine phosphoribosyl transferase 1 Glycosyl transferase 97
GR Glucocorticoid receptor Transcription factor 101
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dard deviations ranging from 0.9 for HPRT and B2M
to 1.2 for GAPDH (Figure 3).
The expression stability of the selected refer-
ence genes was further assessed using the GeNorm
and the NormFinder software (Table III). GeNorm
calculates the stability value M using a pair-wise
comparison approach, thus grading the potential
reference genes according to the similarity of
expression profiles across the sample set (18). Low
M value corresponds to high expression stability. All
the investigated genes exhibited high expression sta-
bility with M-values less than 0.44, which is below
the algorithm defined cut-off value of 1.5 (Table III)
(18). After a step-wise exclusion of the least stable
genes (highest M-values), M-values were recalculat-
ed. GeNorm identified the combination of HPRT
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Figure 3 The Ct value ranges of potential reference genes.
Box represents second and third quartiles, while the median
is shown as a central line, and whiskers extend to smallest
and largest non-outlier values.
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Figure 4 GeNorm output: gene expression stability of BA,
GAPDH, B2M and HPRT. Reference genes are ranked in
order of their expression stability and presented at x axis.
Stability values (M) are presented at y axis. 
Table III Expression stability values of BA, B2M, GAPDH
and HPRT calculated by GeNorm and NormFinder software. 
Gene
GeNorm
Stability value (M)
NormFinder
Stability value (M)
BA 0.368 0.024
B2M 0.373 0.038
GAPDH 0.435 0.031
HPRT 0.338 0.023
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and B2M as the most stable one, with the combined
M-value equal to 0.26 (Figure 4).
NormFinder uses a model-based approach for
identifying the most stable genes based on the least
inter- and intra-group expression variations (19). In
contrast to GeNorm, NormFinder pointed to the
HPRT and BA combination as the most stable one in
PBMCs of women with PCOS and healthy controls,
with its stability value of 0.022. As for the individual
genes, HPRT was identified as the most stable gene,
followed by BA, while B2M was identified as the least
stable one (Table III).
Both software packages pointed to HPRT as the
most stable gene in PBMCs of women with PCOS and
healthy controls, while showing differences in the
ranking order of all the other potential references, as
well as in the most stable combinations (Table III).
Discussion
By using the TaqMan real-time RT PCR method,
we determined variability in the expression of four
potential reference genes: BA, B2M, GAPDH and
HPRT, in order to identify the most stable reference
for further investigations of gene expression in PBMCs
from normal-weight and obese women with PCOS.
We analyzed amplification efficiencies and gene
expression stabilities of the potential reference genes.
Our study shows that HPRT can be used as a refer-
ence gene for the normalization of gene expression in
PBMCs from normal-weight and obese women with
PCOS. 
Real-time PCR is the standard method for study-
ing gene expression, but the need for accurate data
normalization is vital. Thus, the selection of an appro-
priate endogenous control represents an important
step in the analysis of gene expression (10, 12).
Currently, for the determination of target gene
expression in different pathophysiological states, most
of the researchers use relative quantification meth-
ods, either by using the standard curve method or
the 2-DDCt method. Both of these methods require a
properly selected reference gene for the normaliza-
tion of target gene expression. 
Validation of reference genes represents a time-
consuming and expensive procedure. Yet, it has been
well documented that using non-validated reference
genes may result in incorrect data and misinterpreta-
tion of the results (10, 12). Therefore, before per-
forming RT PCR experiments, it is important to care-
fully examine all the available data on the suitability of
various reference genes that were previously used in
similar experimental conditions, in order to select
potential candidates that are going to be validated for
the specific experimental design. The potential candi-
date genes should be selected so as to avoid possible
co-regulations, and the best way is to use genes
belonging to different functional classes. The gene(s)
which is (are) going to be used as a reference in a
particular experimental design should be expressed at
a constant level between the samples through all
experimental conditions or disease stages (20). In this
study, we investigated four potential reference genes
that belong to different functional classes. Namely,
HPRT is an enzyme involved in nucleotide metabo-
lism, GAPDH is an essential glycolytic enzyme, B2M
is the small subunit of a major histocompatibility com-
plex class I molecule and BA is a ubiquitous cytoskele-
ton protein. 
Increasing concern regarding normalization
using traditional reference genes has led to the de -
velopment of several statistical models and software
packages for the analysis of candidate gene stability,
in order to help identify the best reference genes (18,
19, 21). GeNorm is the most frequently used soft-
ware for the analysis of candidate gene stability. This
algorithm operates on the assumption that the ratio of
two ideal reference genes should be constant regard-
less of the experimental conditions. GeNorm uses a
pair-wise comparison approach and ranks genes
according to the similarity of their expression profiles,
rather than minimal variation (18). On the other
hand, NormFinder uses a model-based approach for
the identification of the most stable genes based on
the least inter- and intra-group expression variations
(19).
In this study, we analyzed the expression stabi lity
of four commonly used reference genes (HPRT, BA,
GAPDH and B2M) and showed that HPRT can be
used as a suitable reference for further studies of
gene expression in PBMCs of women with PCOS,
and, in addition, for studies focusing on the connec-
tion of PCOS and obesity. All the examined reference
genes in this study had amplification efficiencies close
to 100%, and all performed well as compared to the
GR, taken as an example target gene. The direct
comparison of Ct values of BA, B2M, GAPDH and
HPRT showed marked inter-individual variations for
all four validated genes, whereas the Ct values of
HPRT were among those less variable. The expres-
sion stability was further assessed by GeNorm and
NormFinder and both softwares identified HPRT as
the most stable gene, while the ranking order of other
examined genes differed. Namely, GeNorm identified
GAPDH, while Norm Finder pointed to B2M as the
least stable gene. Moreover, the best combination
calculated by GeNorm was HPRT and B2M, while
HPRT and BA appeared to be the best combination
according to NormFinder. The observed discrepancy
in the ranking of gene stabilities between the two
algorithms is not unusual and may be explained by
the different methodologies used to calculate the
gene stability. 
Although the GeNorm and NormFinder algo-
rithms significantly simplified the time-consuming
J Med Biochem 2014; 33 (4) 361
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process of data analysis during the selection of suit-
able reference genes, these approaches are still
underutilized. Instead, in most of the previous studies,
traditional housekeeping genes were used as refer-
ences, without any validation. To date, only a few
research groups used validated reference genes for
gene expression studies in various tissues from
women with PCOS, while most of the authors used
GAPDH and 18S RNA without prior validation. Sadek
et al. (22) validated nine reference genes and sug-
gested using tyrosine-3 monooxygenase/tryptophan-
5 monooxygenase activation protein, zeta polypeptide
(YWHAZ), cyto chrome c1 (CYC1) and BA as suitable
references for gene expression studies on endome -
trial tissue from women with PCOS. HPRT and B2M
were not among the nine validated endogenous con-
trols. GAPDH was shown as unsuitable, while BA was
one of the most stable genes (22). Lindholm et al.
(23) investigated the gene expression pattern of
inflammation markers in abdominal superficial subcu-
taneous tissue from overweight and lean patients with
PCOS and overweight controls. The authors used the
NormFinder algorithm to examine the expression sta-
bility of low density lipoprotein receptor-related pro-
tein 10 (LRP10), peptidylprolyl isomerase A (PPIA)
and acidic ribosomal phosphoprotein P0 (RPLP0) and
identified RPLP0 as the best reference. Up to now,
there have been no reports on reference gene stabil-
ity in the PBMCs of patients with PCOS. Our study
shows that HPRT can be used for the normalization of
gene expression in PBMCs from normal-weight and
obese women with PCOS.
Conclusion
Cross-validation of the expression stability of
four potential reference genes by the direct compari-
son of Ct values and by using two software packages,
GeNorm and NormFinder, identified HPRT as the
most stable reference gene for gene expression stud-
ies in PBMCs from normal-weight and obese women
with the polycystic ovary syndrome.
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